Top in women’s health: Treating menopause symptoms; statins lower breast cancer death risk
Click Here to Manage Email Alerts
Researchers in Peru tested the efficacy of an oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids in alleviating menopause symptoms.
They found that the herbal supplement was associated with reductions in global, physical and psychosocial menopause symptom scores compared with hormone therapy. It was the top story in women’s health last week.
The second top story was about a study that found patients who used statins after receiving a breast cancer diagnosis had a lower risk for breast cancer mortality compared with those who did not use statins. Researchers reported that breast cancer mortality risk reduction was greatest for those whose cholesterol levels decreased with statin use.
Read these and more top stories in women’s health below:
Reduced menopause symptoms with herbal supplement vs. hormone therapy
An oral herbal supplement with glucosinolates, phytosterols and citrus flavonoids was associated with some improved menopausal symptoms short term compared with estrogen plus progestogen therapy, researchers reported in Menopause. Read more.
Statin use tied to lower breast cancer death risk
Statin use after breast cancer diagnosis was associated with reduced breast cancer mortality and reduced serum cholesterol levels compared with not using a statin, according to cohort study results published in JAMA Network Open. Read more.
Actively monitoring cervical lesions increases long-term cervical cancer risk
Women who underwent active surveillance for cervical intraepithelial neoplasia grade 2 had an increased long-term risk for cervical cancer compared with women who received immediate treatment, according to findings published in The BMJ. Read more.
About 1% of mothers had new persistent opioid use in the first postpartum year
About 1% of women who filled an opioid prescription after childbirth had evidence of persistent opioid use in the subsequent postpartum year, researchers reported in Obstetrics & Gynecology. Read more.
Consuming energy drinks before pregnancy may raise risk for gestational hypertension
Energy drink consumption before pregnancy was associated with an increased risk for gestational hypertension, researchers reported in JAMA Network Open. Read more.